Similar articles

• Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.

  Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, Keavney B, Ye Z, Danesh J. Thompson A, et al. JAMA. 2008 Jun 18;299(23):2777-88. doi: 10.1001/jama.299.23.2777. JAMA. 2008. PMID: 18560005 Review.
• Future of cholesteryl ester transfer protein inhibitors.

  Rader DJ, deGoma EM. Rader DJ, et al. Annu Rev Med. 2014;65:385-403. doi: 10.1146/annurev-med-050311-163305. Annu Rev Med. 2014. PMID: 24422575 Review.
• Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population.

  Padmaja N, Kumar RM, Balachander J, Adithan C. Padmaja N, et al. Clin Chim Acta. 2009 Apr;402(1-2):139-45. doi: 10.1016/j.cca.2008.12.041. Epub 2009 Jan 12. Clin Chim Acta. 2009. PMID: 19168039
• Increased coronary heart disease risk determined by high high-density lipoprotein cholesterol and C-reactive protein: modulation by variation in the CETP gene.

  Dullaart RP. Dullaart RP. Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1502-3. doi: 10.1161/ATVBAHA.110.209544. Arterioscler Thromb Vasc Biol. 2010. PMID: 20631348 No abstract available.
• [Polymorphism of the CETP gene promoter region and its influence on protein activity in coronary heart disease].

  Sharafetdinova LM, Ismagilova RK, Maĭkova EV, Podol'skaia AA, Kravtsova OA. Sharafetdinova LM, et al. Tsitologiia. 2014;56(6):462-4. Tsitologiia. 2014. PMID: 25696989 Russian.